While the trend for overall private drugs is up only one per cent, prescription drug benefits continue to be threatened
Depending on the conditions for which they are being treated, up to 70 per cent of Canadian patients are not taking thei
Group plan members with high-cost chronic conditions drive almost 80 per cent of plan costs with an average annual drug
The cost of specialty prescription drugs to treat conditions like cancer and hepatitis has doubled over the past decade,
Empire Life has announced that its drug specialty program, part of the Empire Life Actively Managed Drug Solutions portf
Empire Life announced the launch of an actively-managed drug solutions program to help employers manage the costs of the
The growing influx of costly drugs plus the proliferation of large claimants is threatening the survival of group insura